The latest from Innovu: Monitoring GLP-1 Drug Utilization

Spending on GLP-1 drugs is climbing, affecting both your diabetic and non-diabetic employees. As this trend continues, it’s important to look beyond the cost and understand the broader impact on
your health plan. Innovu‘s software, InnovuLens, was created to help navigate the complexities of data integration and analytics in the healthcare benefits space. 

Read their latest Did You Know to find out more!

Did-You-Know-GLP1-Utilization-PBGH

Post a Comment

Your email address will not be published. Required fields are marked *

Get Involved

Becoming a member, signing up as a partner or sponsor, and joining us at an event are all great
ways to connect with what PBGH is doing in your community!

learn more